1 00:00:00,843 --> 00:00:02,888 I'd like to show you a video of some of the models 2 00:00:02,888 --> 00:00:04,477 I work with. 3 00:00:04,477 --> 00:00:08,015 They're all the perfect size, and they don't have an ounce of fat. 4 00:00:08,015 --> 00:00:10,553 Did I mention they're gorgeous? 5 00:00:10,553 --> 00:00:13,683 And they're scientific models? (Laughs) 6 00:00:13,683 --> 00:00:16,026 As you might have guessed, I'm a tissue engineer, 7 00:00:16,026 --> 00:00:18,475 and this is a video of some of the beating heart 8 00:00:18,475 --> 00:00:20,691 that I've engineered in the lab. 9 00:00:20,691 --> 00:00:22,573 And one day we hope that these tissues 10 00:00:22,573 --> 00:00:25,517 can serve as replacement parts for the human body. 11 00:00:25,517 --> 00:00:27,797 But what I'm going to tell you about today 12 00:00:27,797 --> 00:00:32,244 is how these tissues make awesome models. 13 00:00:32,244 --> 00:00:34,971 Well, let's think about the drug screening process for a moment. 14 00:00:34,971 --> 00:00:37,949 You go from drug formulation, lab testing, animal testing, 15 00:00:37,949 --> 00:00:40,452 and then clinical trials, which you might call human testing, 16 00:00:40,452 --> 00:00:42,717 before the drugs get to market. 17 00:00:42,717 --> 00:00:45,860 It costs a lot of money, a lot of time, 18 00:00:45,860 --> 00:00:48,670 and sometimes, even when a drug hits the market, 19 00:00:48,670 --> 00:00:52,605 it acts in an unpredictable way and actually hurts people. 20 00:00:52,605 --> 00:00:56,692 And the later it fails, the worse the consequences. 21 00:00:56,692 --> 00:01:00,876 It all boils down to two issues. One, humans are not rats, 22 00:01:00,876 --> 00:01:04,964 and two, despite our incredible similarities to one another, 23 00:01:04,964 --> 00:01:07,405 actually those tiny differences between you and I 24 00:01:07,405 --> 00:01:09,914 have huge impacts with how we metabolize drugs 25 00:01:09,914 --> 00:01:11,783 and how those drugs affect us. 26 00:01:11,783 --> 00:01:14,615 So what if we had better models in the lab 27 00:01:14,615 --> 00:01:17,885 that could not only mimic us better than rats 28 00:01:17,885 --> 00:01:21,805 but also reflect our diversity? 29 00:01:21,805 --> 00:01:25,732 Let's see how we can do it with tissue engineering. 30 00:01:25,732 --> 00:01:28,261 One of the key technologies that's really important 31 00:01:28,261 --> 00:01:31,453 is what's called induced pluripotent stem cells. 32 00:01:31,453 --> 00:01:33,971 They were developed in Japan pretty recently. 33 00:01:33,971 --> 00:01:36,418 Okay, induced pluripotent stem cells. 34 00:01:36,418 --> 00:01:38,531 They're a lot like embryonic stem cells 35 00:01:38,531 --> 00:01:40,748 except without the controversy. 36 00:01:40,748 --> 00:01:43,647 We induce cells, okay, say, skin cells, 37 00:01:43,647 --> 00:01:46,154 by adding a few genes to them, culturing them, 38 00:01:46,154 --> 00:01:47,775 and then harvesting them. 39 00:01:47,775 --> 00:01:50,482 So they're skin cells that can be tricked, 40 00:01:50,482 --> 00:01:53,266 kind of like cellular amnesia, into an embryonic state. 41 00:01:53,266 --> 00:01:55,978 So without the controversy, that's cool thing number one. 42 00:01:55,978 --> 00:01:58,527 Cool thing number two, you can grow any type of tissue 43 00:01:58,527 --> 00:02:01,082 out of them: brain, heart, liver, you get the picture, 44 00:02:01,082 --> 00:02:03,605 but out of your cells. 45 00:02:03,605 --> 00:02:07,170 So we can make a model of your heart, your brain 46 00:02:07,170 --> 00:02:09,802 on a chip. 47 00:02:09,802 --> 00:02:12,658 Generating tissues of predictable density and behavior 48 00:02:12,658 --> 00:02:15,490 is the second piece, and will be really key towards 49 00:02:15,490 --> 00:02:18,162 getting these models to be adopted for drug discovery. 50 00:02:18,162 --> 00:02:21,274 And this is a schematic of a bioreactor we're developing in our lab 51 00:02:21,274 --> 00:02:24,722 to help engineer tissues in a more modular, scalable way. 52 00:02:24,722 --> 00:02:28,121 Going forward, imagine a massively parallel version of this 53 00:02:28,121 --> 00:02:30,458 with thousands of pieces of human tissue. 54 00:02:30,458 --> 00:02:34,506 It would be like having a clinical trial on a chip. 55 00:02:34,506 --> 00:02:38,301 But another thing about these induced pluripotent stem cells 56 00:02:38,301 --> 00:02:40,850 is that if we take some skin cells, let's say, 57 00:02:40,850 --> 00:02:43,026 from people with a genetic disease 58 00:02:43,026 --> 00:02:45,282 and we engineer tissues out of them, 59 00:02:45,282 --> 00:02:47,250 we can actually use tissue-engineering techniques 60 00:02:47,250 --> 00:02:50,651 to generate models of those diseases in the lab. 61 00:02:50,651 --> 00:02:54,235 Here's an example from Kevin Eggan's lab at Harvard. 62 00:02:54,235 --> 00:02:56,525 He generated neurons 63 00:02:56,525 --> 00:02:59,240 from these induced pluripotent stem cells 64 00:02:59,240 --> 00:03:01,869 from patients who have Lou Gehrig's Disease, 65 00:03:01,869 --> 00:03:04,312 and he differentiated them into neurons, and what's amazing 66 00:03:04,312 --> 00:03:07,464 is that these neurons also show symptoms of the disease. 67 00:03:07,464 --> 00:03:09,563 So with disease models like these, we can fight back 68 00:03:09,563 --> 00:03:12,145 faster than ever before and understand the disease better 69 00:03:12,145 --> 00:03:16,108 than ever before, and maybe discover drugs even faster. 70 00:03:16,108 --> 00:03:19,488 This is another example of patient-specific stem cells 71 00:03:19,488 --> 00:03:23,497 that were engineered from someone with retinitis pigmentosa. 72 00:03:23,497 --> 00:03:25,251 This is a degeneration of the retina. 73 00:03:25,251 --> 00:03:28,008 It's a disease that runs in my family, and we really hope 74 00:03:28,008 --> 00:03:30,232 that cells like these will help us find a cure. 75 00:03:30,232 --> 00:03:33,040 So some people think that these models sound well and good, 76 00:03:33,040 --> 00:03:36,481 but ask, "Well, are these really as good as the rat?" 77 00:03:36,481 --> 00:03:39,469 The rat is an entire organism, after all, 78 00:03:39,469 --> 00:03:41,175 with interacting networks of organs. 79 00:03:41,175 --> 00:03:45,096 A drug for the heart can get metabolized in the liver, 80 00:03:45,096 --> 00:03:47,936 and some of the byproducts may be stored in the fat. 81 00:03:47,936 --> 00:03:52,463 Don't you miss all that with these tissue-engineered models? 82 00:03:52,463 --> 00:03:54,577 Well, this is another trend in the field. 83 00:03:54,577 --> 00:03:57,444 By combining tissue engineering techniques with microfluidics, 84 00:03:57,444 --> 00:03:59,608 the field is actually evolving towards just that, 85 00:03:59,608 --> 00:04:02,114 a model of the entire ecosystem of the body, 86 00:04:02,114 --> 00:04:04,514 complete with multiple organ systems to be able to test 87 00:04:04,514 --> 00:04:06,117 how a drug you might take for your blood pressure 88 00:04:06,117 --> 00:04:09,384 might affect your liver or an antidepressant might affect your heart. 89 00:04:09,384 --> 00:04:13,456 These systems are really hard to build, but we're just starting to be able to get there, 90 00:04:13,456 --> 00:04:16,760 and so, watch out. 91 00:04:16,760 --> 00:04:19,392 But that's not even all of it, because once a drug is approved, 92 00:04:19,392 --> 00:04:23,074 tissue engineering techniques can actually help us develop more personalized treatments. 93 00:04:23,074 --> 00:04:26,816 This is an example that you might care about someday, 94 00:04:26,816 --> 00:04:28,936 and I hope you never do, 95 00:04:28,936 --> 00:04:31,456 because imagine if you ever get that call 96 00:04:31,456 --> 00:04:34,664 that gives you that bad news that you might have cancer. 97 00:04:34,664 --> 00:04:37,200 Wouldn't you rather test to see if those cancer drugs 98 00:04:37,200 --> 00:04:39,960 you're going to take are going to work on your cancer? 99 00:04:39,960 --> 00:04:42,382 This is an example from Karen Burg's lab, where they're 100 00:04:42,382 --> 00:04:45,288 using inkjet technologies to print breast cancer cells 101 00:04:45,288 --> 00:04:47,759 and study its progressions and treatments. 102 00:04:47,759 --> 00:04:50,312 And some of our colleagues at Tufts are mixing models 103 00:04:50,312 --> 00:04:53,400 like these with tissue-engineered bone to see how cancer 104 00:04:53,400 --> 00:04:56,120 might spread from one part of the body to the next, 105 00:04:56,120 --> 00:04:58,504 and you can imagine those kinds of multi-tissue chips 106 00:04:58,504 --> 00:05:01,489 to be the next generation of these kinds of studies. 107 00:05:01,489 --> 00:05:03,911 And so thinking about the models that we've just discussed, 108 00:05:03,911 --> 00:05:05,824 you can see, going forward, that tissue engineering 109 00:05:05,824 --> 00:05:08,280 is actually poised to help revolutionize drug screening 110 00:05:08,280 --> 00:05:11,058 at every single step of the path: 111 00:05:11,058 --> 00:05:13,632 disease models making for better drug formulations, 112 00:05:13,632 --> 00:05:17,503 massively parallel human tissue models helping to revolutionize lab testing, 113 00:05:17,503 --> 00:05:21,728 reduce animal testing and human testing in clinical trials, 114 00:05:21,728 --> 00:05:23,420 and individualized therapies that disrupt 115 00:05:23,420 --> 00:05:27,008 what we even consider to be a market at all. 116 00:05:27,008 --> 00:05:29,552 Essentially, we're dramatically speeding up that feedback 117 00:05:29,552 --> 00:05:31,875 between developing a molecule and learning about 118 00:05:31,875 --> 00:05:34,224 how it acts in the human body. 119 00:05:34,224 --> 00:05:36,552 Our process for doing this is essentially transforming 120 00:05:36,552 --> 00:05:41,413 biotechnology and pharmacology into an information technology, 121 00:05:41,413 --> 00:05:44,392 helping us discover and evaluate drugs faster, 122 00:05:44,392 --> 00:05:47,608 more cheaply and more effectively. 123 00:05:47,608 --> 00:05:51,688 It gives new meaning to models against animal testing, doesn't it? 124 00:05:51,688 --> 00:05:58,503 Thank you. (Applause)